Insight into mithramycin disruption of ETS transcription leads to improved understanding of more selective analogs.

Structure

Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA; Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702, USA. Electronic address:

Published: May 2021

Fusion products with the ETS family of transcription factors play critical roles in the etiology of several cancers. In this issue of Structure, Hou et al. (2020) provide insight into allosteric mechanisms by which mithramycin and its analogs perturb protein-DNA interactions in higher-order complexes at a DNA enhancer site.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.str.2021.03.010DOI Listing

Publication Analysis

Top Keywords

insight mithramycin
4
mithramycin disruption
4
disruption ets
4
ets transcription
4
transcription leads
4
leads improved
4
improved understanding
4
understanding selective
4
selective analogs
4
analogs fusion
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!